Science news

Celltrion USA signs agreement with Express Scripts for its therapy for autoimmune diseases including the first FDA-approved subcutaneous infliximab ZYMFENTRA™

World Reviewer Staff - April 28, 2024 8:05pm EDT

Read the latest science news headlines and see what’s new in science. WeeklyReviewer brings you top science headlines from leading industry news.

Science is a rapidly changing and growing platform. Make sure you are always up to date on what’s new in science!

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO...

April 15, 2024 1:09am EDT

-- Gilead Awards US$4 Million Globally (Excluding the United States) Through The Gilead ALL4LIVER Grant -- -- World Hepatitis Alliance Supports Global Expansion of Gilead...

Unveil Your True Self: Shapellx Announces Launch of New INNER ARMOR Shapewear Collection

April 14, 2024 7:08pm EDT

ORLANDO, Fla., April 14, 2024 /PRNewswire/ -- Shapellx, a leading women's shapewear brand, is thrilled to announce the official launch of its latest INNER...

Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results

April 14, 2024 1:07pm EDT

Q2 Fiscal 2024 Highlights Cash position of $6.6 million as of February 29, 2024Gross profit of $0.5 million, a 22.7% decline over Q1 2024Revenue of...

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

April 14, 2024 7:06am EDT

SHANGHAI, April 13, 2024 /PRNewswire/ -- On Apr. 11, 2024, VITAL HealthCare, one of the 5 core business divisions of the VITAL Group, marked a...

Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates

April 14, 2024 1:05am EDT

Biohaven's first-in-class Molecular Degrader of Extracellular Proteins (MoDE™) technology targeting IgG removal, BHV-1300, was selected for an oral presentation at AAN highlighting its novel...